Budapest, Hungary

Csaba Szantai

This inventor holds 1 USPTO granted patent. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Csaba Szantai. Retrieved from https://idiyas.com/inventor/csaba-szantai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Csaba Szantai

Introduction

Csaba Szantai is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on adrenergic antagonists. His research and inventions have the potential to impact various medical applications.

Latest Patents

Csaba Szantai holds a patent for "Berban derivatives as α2-adrenergic antagonists." This invention relates to novel racemic or optically active berban derivatives, which are characterized by specific chemical structures. The formula involves components where R1 and R2 can represent hydroxyl or alkoxy groups, contributing to the development of new therapeutic agents.

Career Highlights

Throughout his career, Szantai has been associated with Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a prominent pharmaceutical company. His work there has allowed him to focus on innovative drug development and contribute to advancements in medical science.

Collaborations

He has collaborated with notable colleagues such as Szilveszter Vizi and Lajos Szabo, enhancing the research and development efforts within his field. Their combined expertise has fostered a productive environment for innovation.

Conclusion

Csaba Szantai's contributions to the field of pharmaceuticals through his patent on berban derivatives exemplify the importance of innovation in medicine. His work continues to inspire advancements that may lead to improved therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…